{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:32:42Z","timestamp":1787963562101,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["981604"],"award-info":[{"award-number":["981604"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06710-0","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:52:07Z","timestamp":1751464327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Performance of KRAS mutation detection in plasma exosomes from patients with early-stage colorectal cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Mehraneh","family":"Nouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Mozaffari-Jovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Abbaszadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"3","key":"6710_CR1","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA: A Cancer. J Clin. 2023;73(3):233\u201354.","journal-title":"J Clin"},{"issue":"9","key":"6710_CR2","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/cancers13092025","volume":"13","author":"T Sawicki","year":"2021","unstructured":"Sawicki T, Ruszkowska M, Danielewicz A, Nied\u017awiedzka E, Ar\u0142ukowicz T, Przyby\u0142owicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers. 2021;13(9):2025.","journal-title":"Cancers"},{"key":"6710_CR3","doi-asserted-by":"publisher","first-page":"114786","DOI":"10.1016\/j.biopha.2023.114786","volume":"163","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang Y, Zhang B, Li P, Zhao Y. Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancer. Biomed Pharmacother. 2023;163:114786.","journal-title":"Biomed Pharmacother"},{"key":"6710_CR4","doi-asserted-by":"publisher","first-page":"111717","DOI":"10.1016\/j.biopha.2021.111717","volume":"140","author":"M Meng","year":"2021","unstructured":"Meng M, Zhong K, Jiang T, Liu Z, Kwan HY, Su T. The current Understanding on the impact of KRAS on colorectal cancer. Biomed Pharmacother. 2021;140:111717.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"6710_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","volume":"32","author":"W Yu","year":"2021","unstructured":"Yu W, Hurley J, Roberts D, Chakrabortty SK, Enderle D, Noerholm M, et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann Oncol. 2021;32(4):466\u201377.","journal-title":"Ann Oncol"},{"issue":"1","key":"6710_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12943-022-01556-2","volume":"21","author":"H Zhou","year":"2022","unstructured":"Zhou H, Zhu L, Song J, Wang G, Li P, Li W, et al. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer. Mol Cancer. 2022;21(1):86.","journal-title":"Mol Cancer"},{"issue":"1","key":"6710_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.currproblcancer.2017.11.002","volume":"42","author":"Y Tan","year":"2018","unstructured":"Tan Y, Wu H. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis. Curr Probl Cancer. 2018;42(1):95\u2013106.","journal-title":"Curr Probl Cancer"},{"issue":"10","key":"6710_CR8","doi-asserted-by":"publisher","first-page":"e00088","DOI":"10.14309\/ctg.0000000000000088","volume":"10","author":"WS Tsai","year":"2019","unstructured":"Tsai WS, You JF, Hung HY, Hsieh PS, Hsieh B, Lenz HJ, et al. Novel Circulating tumor cell assay for detection of colorectal adenomas and Cancer. Clin Transl Gastroenterol. 2019;10(10):e00088.","journal-title":"Clin Transl Gastroenterol"},{"issue":"8","key":"6710_CR9","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1245\/s10434-020-09449-8","volume":"28","author":"S Kobayashi","year":"2021","unstructured":"Kobayashi S, Nakamura Y, Taniguchi H, Odegaard JI, Nomura S, Kojima M, et al. Impact of preoperative Circulating tumor DNA status on survival outcomes after hepatectomy for resectable colorectal liver metastases. Ann Surg Oncol. 2021;28(8):4744\u201355.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"6710_CR10","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","volume":"5","author":"J Tie","year":"2019","unstructured":"Tie J, Cohen JD, Wang Y, Christie M, Simons K, Lee M, et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III Colon cancer. JAMA Oncol. 2019;5(12):1710\u20137.","journal-title":"JAMA Oncol"},{"issue":"5","key":"6710_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/pgs-2018-0174","volume":"20","author":"P Muluhngwi","year":"2019","unstructured":"Muluhngwi P, Valdes R Jr., Fernandez-Botran R, Burton E, Williams B, Linder MW. Cell-free DNA diagnostics: current and emerging applications in oncology. Pharmacogenomics. 2019;20(5):357\u201380.","journal-title":"Pharmacogenomics"},{"key":"6710_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms21186907","volume":"21","author":"L Raimondi","year":"2020","unstructured":"Raimondi L, Raimondi FM, Di Benedetto L, Cimino G, Spinelli GP. PD-L1 expression on Circulating tumour cells May be predictive of response to regorafenib in patients diagnosed with chemorefractory metastatic colorectal Cancer. Int J Mol Sci. 2020;21:18.","journal-title":"Int J Mol Sci"},{"key":"6710_CR13","doi-asserted-by":"crossref","unstructured":"Hur JY, Lee KY. Characteristics and clinical application of extracellular Vesicle-Derived DNA. Cancers (Basel). 2021;13(15).","DOI":"10.3390\/cancers13153827"},{"issue":"7","key":"6710_CR14","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","volume":"289","author":"C Kahlert","year":"2014","unstructured":"Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M, et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem. 2014;289(7):3869\u201375.","journal-title":"J Biol Chem"},{"issue":"4","key":"6710_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/annonc\/mdx004","volume":"28","author":"K Allenson","year":"2017","unstructured":"Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, et al. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Ann Oncol. 2017;28(4):741\u20137.","journal-title":"Ann Oncol"},{"issue":"1","key":"6710_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1186\/s12885-018-5138-3","volume":"18","author":"JS Lee","year":"2018","unstructured":"Lee JS, Hur JY, Kim IA, Kim HJ, Choi CM, Lee JC, et al. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA. BMC Cancer. 2018;18(1):1236.","journal-title":"BMC Cancer"},{"key":"6710_CR17","doi-asserted-by":"crossref","unstructured":"Choi J, Cho HY, Jeon J, Kim K-A, Han YD, Ahn JB et al. Detection of Circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer. Front Oncol. 2022;12.","DOI":"10.3389\/fonc.2022.1067210"},{"key":"6710_CR18","doi-asserted-by":"publisher","first-page":"104796","DOI":"10.1016\/j.jddst.2023.104796","volume":"87","author":"S Sharif","year":"2023","unstructured":"Sharif S, Mozaffari-Jovin S, Alizadeh F, Mojarrad M, Baharvand H, Nouri M, Abbaszadegan MR. Isolation of plasma small extracellular vesicles by an optimized size-exclusion chromatography-based method for clinical applications. J Drug Deliv Sci Technol. 2023;87:104796.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"6710_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.molonc.2014.02.005","volume":"8","author":"F Mouliere","year":"2014","unstructured":"Mouliere F, El Messaoudi S, Pang D, Dritschilo A, Thierry AR. Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer. Mol Oncol. 2014;8(5):927\u201341.","journal-title":"Mol Oncol"},{"key":"6710_CR20","doi-asserted-by":"crossref","unstructured":"Thierry A, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med. 2014;20.","DOI":"10.1038\/nm.3511"},{"issue":"3","key":"6710_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1593\/tlo.12445","volume":"6","author":"F Mouliere","year":"2013","unstructured":"Mouliere F, El Messaoudi S, Gongora C, Guedj AS, Robert B, Del Rio M, et al. Circulating Cell-Free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load. Transl Oncol. 2013;6(3):319\u201328.","journal-title":"Transl Oncol"},{"key":"6710_CR22","doi-asserted-by":"crossref","unstructured":"Zhang K, Fu R, Liu R, Su Z. Circulating cell-free DNA-based early detection. Trends Cancer. 2023.","DOI":"10.1016\/j.trecan.2023.08.010"},{"issue":"5","key":"6710_CR23","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3390\/cancers15051456","volume":"15","author":"I Tatischeff","year":"2023","unstructured":"Tatischeff I. Extracellular Vesicle-DNA: the next liquid biopsy biomarker for early cancer diagnosis?? Cancers. 2023;15(5):1456.","journal-title":"Cancers"},{"key":"6710_CR24","doi-asserted-by":"crossref","unstructured":"Lo YMD, Han DSC, Jiang P, Chiu RWK. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science. 2021;372(6538).","DOI":"10.1126\/science.aaw3616"},{"issue":"6","key":"6710_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/cr.2014.44","volume":"24","author":"BK Thakur","year":"2014","unstructured":"Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24(6):766\u20139.","journal-title":"Cell Res"},{"issue":"7","key":"6710_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41419-020-02803-4","volume":"11","author":"EZ Malkin","year":"2020","unstructured":"Malkin EZ, Bratman SV. Bioactive DNA from extracellular vesicles and particles. Cell Death Dis. 2020;11(7):584.","journal-title":"Cell Death Dis"},{"issue":"11","key":"6710_CR27","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1111\/cas.14186","volume":"110","author":"K Takeda","year":"2019","unstructured":"Takeda K, Yamada T, Takahashi G, Iwai T, Ueda K, Kuriyama S, et al. Analysis of colorectal cancer-related mutations by liquid biopsy: utility of Circulating cell-free DNA and circulating tumor cells. Cancer Sci. 2019;110(11):3497\u2013509.","journal-title":"Cancer Sci"},{"issue":"2","key":"6710_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/ph14020128","volume":"14","author":"S Galbiati","year":"2021","unstructured":"Galbiati S, Damin F, Brambilla D, Ferraro L, Soriani N, Ferretti AM, et al. Small EVs-Associated DNA as complementary biomarker to circulating tumor DNA in plasma of metastatic colorectal cancer patients. Pharmaceuticals. 2021;14(2):128.","journal-title":"Pharmaceuticals"},{"issue":"30","key":"6710_CR29","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.18632\/oncotarget.26885","volume":"10","author":"E Castellanos-Rizaldos","year":"2019","unstructured":"Castellanos-Rizaldos E, Zhang X, Tadigotla VR, Grimm DG, Karlovich C, Raez LE, Skog JK. Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients. Oncotarget. 2019;10(30):2911\u201320.","journal-title":"Oncotarget"},{"issue":"1","key":"6710_CR30","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1038\/s41467-019-11530-0","volume":"10","author":"IG Serebriiskii","year":"2019","unstructured":"Serebriiskii IG, Connelly C, Frampton G, Newberg J, Cooke M, Miller V, et al. Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. Nat Commun. 2019;10(1):3722.","journal-title":"Nat Commun"},{"issue":"16","key":"6710_CR31","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1158\/1078-0432.CCR-17-0232","volume":"23","author":"AR Thierry","year":"2017","unstructured":"Thierry AR, Pastor B, Jiang ZQ, Katsiampoura AD, Parseghian C, Loree JM, et al. Circulating DNA demonstrates convergent evolution and common resistance mechanisms during treatment of colorectal Cancer. Clin Cancer Res. 2017;23(16):4578\u201391.","journal-title":"Clin Cancer Res"},{"key":"6710_CR32","doi-asserted-by":"publisher","first-page":"558106","DOI":"10.3389\/fonc.2020.558106","volume":"10","author":"ZY Wang","year":"2020","unstructured":"Wang ZY, Wang RX, Ding XQ, Zhang X, Pan XR, Tong JH. A protocol for cancer-related mutation detection on exosomal DNA in clinical application. Front Oncol. 2020;10:558106.","journal-title":"Front Oncol"},{"issue":"6","key":"6710_CR33","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/annonc\/mdx112","volume":"28","author":"J Grasselli","year":"2017","unstructured":"Grasselli J, Elez E, Carat\u00f9 G, Matito J, Santos C, Macarulla T, et al. Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer. Ann Oncol. 2017;28(6):1294\u2013301.","journal-title":"Ann Oncol"},{"issue":"1","key":"6710_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1053\/j.gastro.2018.09.022","volume":"156","author":"V Bernard","year":"2019","unstructured":"Bernard V, Kim DU, San Lucas FA, Castillo J, Allenson K, Mulu FC, et al. Circulating nucleic acids are associated with outcomes of patients with pancreatic Cancer. Gastroenterology. 2019;156(1):108\u2013e184.","journal-title":"Gastroenterology"},{"key":"6710_CR35","doi-asserted-by":"crossref","unstructured":"Liu X, Lang J, Li S, Wang Y, Peng L, Wang W et al. Fragment enrichment of Circulating tumor DNA with Low-Frequency mutations. Front Genet. 2020;11.","DOI":"10.3389\/fgene.2020.00147"},{"issue":"9","key":"6710_CR36","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1158\/1078-0432.CCR-20-3677","volume":"27","author":"Y Kagawa","year":"2021","unstructured":"Kagawa Y, Elez E, Garc\u00eda-Foncillas J, Bando H, Taniguchi H, Vivancos A, et al. Combined analysis of concordance between liquid and tumor tissue biopsies for RAS mutations in colorectal Cancer with a single metastasis site: the METABEAM study. Clin Cancer Res. 2021;27(9):2515\u201322.","journal-title":"Clin Cancer Res"},{"issue":"39","key":"6710_CR37","doi-asserted-by":"publisher","first-page":"e22407","DOI":"10.1097\/MD.0000000000022407","volume":"99","author":"G Ucar","year":"2020","unstructured":"Ucar G, Ergun Y, Akt\u00fcrk Esen S, Acikgoz Y, Dirikoc M, Esen \u0130, et al. Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer. Med (Baltim). 2020;99(39):e22407.","journal-title":"Med (Baltim)"},{"issue":"8","key":"6710_CR38","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1158\/1078-0432.CCR-22-1749","volume":"29","author":"A Sugimoto","year":"2023","unstructured":"Sugimoto A, Matsumoto S, Udagawa H, Itotani R, Usui Y, Umemura S, et al. A Large-scale prospective concordance study of plasma- and tissue-based next-generation targeted sequencing for advanced non-small cell lung cancer (LC-SCRUM-Liquid). Clin Cancer Res. 2023;29(8):1506\u201314.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"6710_CR39","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00432-020-03267-x","volume":"146","author":"SM Esagian","year":"2020","unstructured":"Esagian SM, Grigoriadou G\u0399, Nikas IP, Boikou V, Sadow PM, Won J-K, Economopoulos KP. Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review. J Cancer Res Clin Oncol. 2020;146(8):2051\u201366.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"6710_CR40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/10520295.2020.1810775","volume":"96","author":"Y Liu","year":"2021","unstructured":"Liu Y, Li L, Tian Y, Zhu X, Sun A, Sun Y, et al. Analysis of KRAS mutations in circulating tumor DNA and colorectal cancer tissue. Biotech Histochem. 2021;96(5):376\u201383.","journal-title":"Biotech Histochem"},{"issue":"28","key":"6710_CR41","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2217\/fon-2020-0523","volume":"16","author":"T Germetaki","year":"2020","unstructured":"Germetaki T, Nicholls C, Adams RA, Braun M, Rogan J, Moghadam S, et al. Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression. Future Oncol. 2020;16(28):2177\u201389.","journal-title":"Future Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06710-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06710-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06710-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:52:10Z","timestamp":1751464330000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06710-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6710"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06710-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read the journal\u2019s policy on disclosure of potential conflicts of interest. The authors declare no competing conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"730"}}